BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1312055)

  • 1. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M; Gavaler JS; Kelly RH; Prieto M; Van Thiel DH
    Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
    Elzouki AN; Eriksson S
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-1-Antitrypsin phenotypes in hepatocellular carcinoma.
    Govindarajan S; Ashcavai M; Peters RL
    Hepatology; 1981; 1(6):628-31. PubMed ID: 6171495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis.
    Rabinovitz M; Gavaler JS; Kelly RH; Van Thiel DH
    Hepatology; 1992 Jul; 16(1):145-8. PubMed ID: 1618466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heterozygous alpha-1-antitrypsin deficiency (PiMZ): risk factor in the development of primary liver carcinoma in non-cirrhotic liver?].
    Manekeller S; Sauerbruch T; Fischer HP; Propping P; Hirner A
    Z Gastroenterol; 2010 Oct; 48(10):1211-4. PubMed ID: 20886426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency.
    Propst T; Propst A; Dietze O; Judmaier G; Braunsteiner H; Vogel W
    J Hepatol; 1994 Dec; 21(6):1006-11. PubMed ID: 7699220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
    Olusi SO
    Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis and hepatocellular carcinoma in a patient with heterozygous (MZ) alpha-1-antitrypsin deficiency.
    Marwick TH; Cooney PT; Kerlin P
    Pathology; 1985 Oct; 17(4):649-52. PubMed ID: 3005953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatocellular carcinoma and the alpha 1-antitrypsin phenotype].
    Labadie H; Sesboué R; Martin JP; Beaugrand M
    Gastroenterol Clin Biol; 1985 Dec; 9(12):881-5. PubMed ID: 3007258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
    Lieberman J; Silton RM; Agliozzo CM; McMahon J
    Am J Clin Pathol; 1975 Sep; 64(3):304-10. PubMed ID: 169686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma?
    Charlionet R; Martin JP; Sesboué R; Ropartz C
    Biomedicine; 1976 Jun; 25(4):125-6. PubMed ID: 60146
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency.
    Zhou H; Fischer HP
    Am J Surg Pathol; 1998 Jun; 22(6):742-8. PubMed ID: 9630182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous alpha 1-antitrypsin deficiency (PiSZ) in an adolescent with asthma.
    Nuckton TJ; Beckerman RC
    South Med J; 1996 Oct; 89(10):1011-3. PubMed ID: 8865800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma?
    Zhou H; Ortiz-Pallardó ME; Ko Y; Fischer HP
    Cancer; 2000 Jun; 88(12):2668-76. PubMed ID: 10870048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse hepatocellular dysplasia and carcinoma associated with the Mmalton variant of alpha 1-antitrypsin.
    Reid CL; Wiener GJ; Cox DW; Richter JE; Geisinger KR
    Gastroenterology; 1987 Jul; 93(1):181-7. PubMed ID: 3034714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
    Rawlings W; Moss J; Cooper HS; Hamilton SR
    Ann Intern Med; 1974 Dec; 81(6):771-3. PubMed ID: 4372920
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is heterozygote alpha 1-antitrypsin deficiency a risk factor in the etiology of aortic aneurysm?].
    Hernandez-Richter T; Schardey HM; Klueppelberg U; Tutsch-Bauer E; Lauterjung L; Schildberg FW
    Chirurg; 1997 May; 68(5):513-6. PubMed ID: 9303842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of children with α-1 antitrypsin deficiency.
    Comba A; Demirbaş F; Çaltepe G; Eren E; Kalayci AG
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):774-778. PubMed ID: 29505478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.